Eiichi Tahara

Eiichi Tahara's AcademicInfluence.com Rankings

Eiichi Tahara

Medical

#2726

World Rank

#3158

Historical Rank

Oncology

#174

World Rank

#180

Historical Rank

medical Degrees

Eiichi Tahara

Philosophy

#7790

World Rank

#11047

Historical Rank

Logic

#4827

World Rank

#6156

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Eiichi Tahara's Degrees

PhD Medical Science University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Eiichi Tahara Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eiichi Tahara's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Frequent amplification of the c-met gene in scirrhous type stomach cancer. (1992) (353)
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. (1988) (347)
Genetic pathways of two types of gastric cancer. (2004) (278)
Cellular and molecular aspects of gastric cancer. (2006) (261)
Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. (1991) (249)
Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine (1997) (206)
Co‐expression of osteopontin and CD44v9 in gastric cancer (1998) (193)
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. (1995) (192)
Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma (1988) (188)
Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. (1990) (180)
Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. (1985) (178)
Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis (1995) (175)
High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. (1989) (174)
Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections (1999) (158)
Molecular mechanism of stomach carcinogenesis (2005) (154)
Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas (1995) (150)
Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach (1996) (143)
Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers. (2000) (141)
Expression of a 31‐kDa lactoside‐binding lectin in normal human gastric Mucosa and in primary and metastatic gastric carcinomas (1994) (140)
Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. (1999) (131)
Expression of the E2F family in human gastrointestinal carcinomas (1999) (127)
Reduced Expression of nm23 Is Associated with Metastasis of Human Gastric Carcinomas (1993) (127)
Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates (1996) (126)
Restoration of the Cellular Senescence Program and Repression of Telomerase by Human Chromosome 3 (1995) (124)
Effect of trichostatin A on cell growth and expression of cell cycle‐ and apoptosis‐related molecules in human gastric and oral carcinoma cell lines (2000) (123)
Scirrhous argyrophil cell carcinoma of the stomach with multiple production of polypeptide hormones, amine, CEA, lysozyme, and HCG (1982) (121)
Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas (1995) (120)
Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. (2000) (120)
Molecular diagnosis of gastric cancer: present and future (2001) (117)
Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas (1993) (116)
Aberrant expression of c‐met mRNA in human gastric carcinomas (1993) (114)
Genetic and epigenetic changes in stomach cancer. (2001) (110)
Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. (2000) (105)
Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. (1999) (101)
Expression of Epidermal Growth Factor, Transforming Growth Factor‐α and Their Receptor Genes in Human Gastric Carcinomas; Implication for Autocrine Growth (1990) (97)
Expression of TGF‐β and procollagen type I and type III in human gastric carcinomas (1989) (97)
Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis (1994) (96)
EXPRESSION OF CYCLIN‐DEPENDENT KINASE INHIBITOR p21WAF1/CIP1 IN NON‐NEOPLASTIC MUCOSA AND NEOPLASIA OF THE STOMACH: RELATIONSHIP WITH p53 STATUS AND PROLIFERATIVE ACTIVITY (1996) (96)
Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. (1996) (89)
Isolation of an Amplified DNA Sequence in Stomach Cancer (1990) (89)
Frequent p53 gene mutations in serrated adenomas of the colorectum (1998) (88)
Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers. (1997) (88)
G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell (2005) (88)
Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. (1984) (87)
In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. (1995) (87)
Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas (1989) (87)
Overexpression of Cyclin‐dependent Kinase‐activating CDC25B Phosphatase in Human Gastric Carcinomas (1997) (84)
Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR‐beta in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomas (2002) (84)
Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. (2001) (83)
Molecular biology of gastric cancer (1995) (82)
[Hereditary non-polyposis colorectal cancer]. (1998) (82)
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. (1997) (81)
Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas (1993) (80)
Interleukin 1α Acts as an Autocrine Growth Stimulator for Human Gastric Carcinoma Cells (1993) (79)
Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. (2000) (78)
Growth factors and oncogenes in human gastrointestinal carcinomas (2005) (77)
Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas (1994) (74)
DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. (2000) (72)
Expression of Human Telomerase RNA Is an Early Event of Stomach Carcinogenesis (1997) (71)
Expression of basic fibroblast growth factor in human gastric carcinomas (1992) (71)
Expression of vascular endothelial growth factor in human gastric carcinomas (1998) (69)
Alterations of oncogenes in metastatic tumours of human gastric carcinomas. (1990) (69)
Telomerase activity in premalignant and malignant lesions of human oral mucosa. (1997) (67)
Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer. (2001) (66)
Overexpression of Retinoic Acid Receptor β Induces Growth Arrest and Apoptosis in Oral Cancer Cell Lines (2001) (66)
Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling. (1992) (64)
The level of a transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas. (1992) (64)
Loss of Heterozygosity at the bcl‐2 Gene Locus and Expression of bcl‐2 in Human Gastric and Colorectal Carcinomas (1994) (64)
Endocrine Cell Carcinoma (Carcinoid) of the Gallbladder (1989) (64)
p53 gene mutations in gastric adenomas (1993) (63)
Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas (1991) (61)
Induction of Growth Factor‐receptor and Metalloproteinase Genes by Epidermal Growth Factor and/or Transforming Growth Factor‐α in Human Gastric Carcinoma Cell Line MKN‐28 (1990) (61)
Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. (1995) (61)
Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues (1996) (59)
Reduced expression of cyclin‐dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma (1998) (58)
Expression of several growth factors and their receptor genes in human colon carcinomas (1990) (58)
Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. (1995) (57)
Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. (1999) (56)
Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. (1997) (56)
Expression of CD44 abnormal transcripts in human gastric carcinomas. (1994) (55)
Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. (1986) (55)
Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. (2001) (55)
Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype (1999) (53)
Reduced Levels of Transforming Growth Factor‐beta Type I Receptor in Human Gastric Carcinomas (1992) (50)
Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer. (1998) (50)
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues (2000) (49)
Expression of Telomerase Catalytic Component, Telomerase Reverse Transcriptase, in Human Gastric Carcinomas (1998) (49)
Amelanotic malignant melanoma of the esophagus: case report and review of the literature. (1990) (49)
THE RELATIONSHIP OF GASTROINTESTINAL ENDOCRINE CELLS TO GASTRIC EPITHELIAL CHANGES WITH SPECIAL REFERENCE TO GASTRIC CANCER (1975) (48)
High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. (1996) (48)
Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. (1986) (47)
Expression of Amphiregulin, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastric Carcinomas (1993) (46)
AMPLIFICATION OF THE hst‐1 GENE IN HUMAN ESOPHAGEAL CARCINOMAS (1988) (45)
Immunohistochemical Detection of Human Telomerase Reverse Transcriptase in Normal Mucosa and Precancerous Lesions of the Stomach (1999) (45)
Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues (1999) (44)
Genetic Status and Expression of the Cyclin‐dependent Kinase Inhibitors in Human Gastric Carcinoma Cell Lines (1996) (43)
Lysozyme in human gastric carcinoma: a retrospective immunohistochemical study (1982) (43)
Molecular aspects of invasion and metastasis of stomach cancer. (2000) (43)
Immunohistochemical Studies on EGF Family Growth Factors in Normal and Ulcerated Human Gastric Mucosa (1997) (41)
p53 point mutations in primary human gastric carcinomas (2005) (41)
Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. (1997) (40)
Expression of epidermal growth factor in human tissues (2005) (40)
LETTER TO THE EDITOR. THE SEQUENTIAL ACCUMULATION OF GENETIC ALTERATIONS CHARACTERISTIC OF THE COLORECTAL ADENOMA‐CARCINOMA SEQUENCE DOES NOT OCCUR BETWEEN GASTRIC ADENOMA AND ADENOCARCINOMA (1996) (40)
Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis (1999) (40)
Immunohistochemical Analysis of Estrogen Receptors in Human Gallbladder (1990) (39)
Growth factors in progression of human esophageal and gastric carcinomas. (1990) (39)
Estrogen receptors in gastric adenocarcinoma: A retrospective immunohistochemical analysis (2004) (39)
Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. (1996) (38)
HISTOLOGICAL CLASSIFICATION OF EPITHELIAL POLYPOID LESIONS OF THE GALLBLADDER (1988) (38)
Expression of Interleukin‐6 and Its Effect on the Cell Growth of Gastric Carcinoma Cell Lines (1997) (38)
Low-Positive Antibody Titer against Helicobacter pylori Cytotoxin-Associated Gene A (CagA) May Predict Future Gastric Cancer Better Than Simple Seropositivity against H. pylori CagA or against H. pylori (2007) (38)
Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. (1991) (37)
Enhanced effect of gastrin on rat stomach carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. (1982) (36)
pp60c‐src protein kinase activity in human gastric carcinomas (1990) (36)
Inhibition of Cell Growth by Transforming Growth Factor β1 Is Associated with p53‐Independent Induction of p21 in Gastric Carcinoma Cells (1996) (36)
Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. (1993) (36)
ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder. (1984) (36)
Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression (1997) (36)
Effect of gastro-entero-pancreatic endocrine hormones on the histogenesis of gastric cancer in rats induced by N-methyl-N'-nitro-N-nitrosoguanidine; with special reference to development of scirrhous gastric cancer. (1975) (36)
Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor α (2005) (36)
Dysplasia of the gallbladder. Its histogenesis and correlation to gallbladder adenocarcinoma. (1989) (35)
Endocrine cells and lysozyme immunoreactivity in the gallbladder. (1986) (35)
Effect of gastrin on gastric mucosal cyclic adenosine 3':5'-monophosphate-dependent protein kinase activity in rat stomach carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. (1985) (35)
Tubular adenoma of the human stomach: An immunohistochemical analysis of gut hormones, serotonin, carcinoembryonic antigen, secretory component, and lysozyme (1986) (35)
Expression of P‐cadherin in gastric carcinomas and its reduction in tumor progression (1993) (35)
Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil. (2004) (34)
Expression of amphiregulin in human gastric cancer cell lines (1995) (34)
PTEN expression is maintained in sporadic colorectal tumours (2001) (33)
In situ mRNA Hybridization Technique for Analysis of Human Telomerase RNA in Gastric Precancerous and Cancerous Lesions (1998) (33)
Helicobactor pylori infection and carcinogenesis of the stomach (2000) (33)
Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. (2007) (33)
DISTRIBUTION OF COLLAGEN TYPES I, III, AND V IN FIBROTIC AND NEOPLASTIC HUMAN LIVER (1984) (32)
Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. (1997) (32)
Molecular–pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology (1999) (32)
Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas. (2000) (31)
Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines. (1999) (31)
Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression. (1995) (31)
Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. (2000) (30)
Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus. (2000) (30)
Telomerase activity in central nervous system malignant lymphoma (1999) (30)
Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene (1995) (29)
DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas (1989) (29)
Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma. (1988) (29)
Coexpression of Platelet‐derived Growth Factor (PDGF) A‐Chain and PDGF Receptor Genes in Human Gastric Carcinomas (1989) (29)
Epidermal Growth Factor Induces the Expression of Its Receptor Gene in Human Gastric Carcinoma Cell Line TMK‐1 (1989) (29)
HUMAN CHORIONIC GONADOTROPIN IN HUMAN GASTRIC CARCINOMA (1983) (29)
Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. (2003) (28)
Hepatoblastoma in an adult associated with c‐met proto‐oncogene imbalance (1996) (27)
Morphometrical analysis of gall-bladder adenoma and adenocarcinoma with reference to histogenesis and adenoma-carcinoma sequence (2005) (27)
Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. (1996) (26)
Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression. (1998) (26)
Effect of human epidermal growth factor on cell growth and its receptor in human gastric carcinoma cell lines. (1988) (26)
Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. (1995) (26)
Silencing of the CD44 Gene by CpG Methylation in a Human Gastric Carcinoma Cell Line (1999) (25)
Glomus tumor of the trachea. Immunohistochemical and electron microscopic studies. (1988) (25)
Regulation of carcinoembryonic antigen expression in human colon carcinoma cells by the organ microenvironment. (1996) (25)
Growth Inhibition of Human Glioma Cells by Transfection-induced P21 and its Effects on Telomerase Activity (2000) (25)
Abnormal Growth Factor/Cytokine Network in Gastric Cancer (2008) (25)
Alterations of the apc gene in carcinoma cell-lines and precancerous lesions of the stomach. (1995) (24)
GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines. (1993) (24)
Expression of transforming growth factor alpha in human tissues: Immunohistochemical study and Northern blot analysis (2005) (24)
Carcinoma of the gallbladder: The correlation between histogenesis and prognosis (2004) (23)
Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene. (1996) (23)
Histogenesis of well-differentiated adenocarcinoma of the gallbladder. (1989) (22)
Infantile hemangioendothelioma of the liver in patient with interstitial deletion of chromosome 6q: report of an autopsy case. (1989) (21)
Ectopic gastric mucosa of the gallbladder: comparison with metaplastic polyp of the gallbladder. (1989) (21)
Pleiotropic phenotypic expression in cybrids derived from mouse teratocarcinoma cells fused with rat myoblast cytoplasts (1985) (21)
Carcinosarcomas of the esophagus (1995) (21)
Endocrine Tumors of the Gastrointestinal Tract: Classification, Function and Biological Behavior (1988) (21)
Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines (2004) (20)
Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma. (1999) (20)
Expression of Cell-Cycle-Regulating Transcription Factor E2F-1 in Colorectal Carcinomas (2000) (20)
HST1 and INT2 gene coamplification in a squamous cell carcinoma of the gallbladder. (1989) (19)
MicroRNAs in Cancer: the 22nd Hiroshima Cancer Seminar/the 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima. (2013) (19)
Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas. (1998) (19)
Expression of cripto in Human Pancreatic Tumors (1994) (19)
Molecular Bases of Human Stomach Carcinogenesis (1997) (19)
Reduced Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in Oral Malignant Tumors (1999) (19)
Secretory differentiation and cell type identification of a human fetal bronchial epithelial cell line (HFBE) (1992) (19)
Site‐selective 8‐C1‐cAMP which causes growth inhibition and differentiation increases DNA (CRE)‐binding activity in cancer cells (1989) (18)
Recent progress in carcinogenesis, progression and therapy of lung cancer: the 19th Hiroshima Cancer Seminar: the 3rd Three Universities' Consortium International Symposium, November 2009. (2010) (18)
Inhibitory Effect of 8‐Chloro‐cyclic Adenosine 3′,5′‐Monophosphate on Cell Growth of Gastric Carcinoma Cell Lines (1991) (18)
Genetic abnormalities and expression of p53 in human colon carcinomas. (1992) (18)
Anthracycline induced myocardial damage. An analysis of 16 autopsy cases. (1986) (18)
Interferon‐alpha prevents selection of doxorubicin‐resistant undifferentiated‐androgen‐insensitive metastatic human prostate cancer cells (2001) (17)
Duodenal Carcinoid (Somatostatinoma) Cornbined with Von Recklinghausen's Disease: A Case Report and Review of the Literature (1989) (17)
No mutations of the Smad2 gene in human sporadic gastric carcinomas. (1999) (17)
Growth Factors in Gastric Cancer (1993) (17)
Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation. (1997) (17)
Cholecystokinin inhibition of tumor growth and gastrin-stimulated cyclic adenosine 3':5'-monophosphate metabolism in human gastric carcinoma in nude mice. (1986) (17)
No mutations of the Bub1 gene in human gastric carcinomas. (2001) (16)
Expression of MRE11 Complex (MRE11, RAD50, NBS1) and hRap1 and Its Relation with Telomere Regulation, Telomerase Activity in Human Gastric Carcinomas (2002) (16)
Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth‐factor/receptor gene expression in human gastric carcinoma cells (1991) (15)
Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers. (2002) (15)
Phyllodes tumor of the prostate: a case report. (1989) (15)
Cutaneous ciliated cyst of the right lower leg (1999) (15)
Minute carcinoid arising in gastric tubular adenoma (1989) (15)
First international workshop of the princess takamatsu cancer research fund: Intestinal metaplasia and gastric cancer (1994) (15)
Flow cytometric DNA analysis of gastric smooth muscle tumors (1992) (15)
Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells. (1987) (14)
Amplified DNA sequences in cancers. (1985) (14)
Type I and II cyclic adenosine 3':5'-monophosphate-dependent protein kinase in human gastric mucosa and carcinomas. (1985) (14)
DNA ploidy patterns in gallbladder adenocarcinoma. (1990) (14)
Molecular Pathology of Gastroenterological Cancer (1997) (14)
Colorectal cancer incidence among atomic bomb survivors, 1950-80. (1992) (14)
Calcium-activated, phospholipid-dependent protein kinase in human gastric mucosa and carcinoma. (1985) (13)
Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions. (1998) (13)
Depressed tubular adenoma of the stomach: pathological and immunohistochemical features (1990) (13)
Giant pigmented tumour of the scalp—a diffuse neurofibroma or a congenital naevus showing neurofibromatous changes? Immunohistochemical and electron microscopic studies (1988) (13)
Cytogenetical analysis of the human gastric carcinoma cell line TMK-1. (1989) (12)
DIFFUSE PAPILLOMATOSIS OF THE GALLBLADDER COMPLICATED WITH TUBERCULOSIS (1988) (12)
Human chorionic gonadotropin in human gastric carcinoma. A retrospective immunohistochemical study. (1983) (12)
Biologic effect of human hepatocyte growth-factor on human gastric-carcinoma cell-lines. (1993) (12)
EXPRESSION OF CRIPTO IN HUMAN GALL BLADDER LESIONS (1996) (11)
Papillary adenoma of the stomach. Pathologic and immunohistochemical study. (1989) (11)
Coamplification of cyclin-d, hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas. (1994) (11)
nm23 expression in carcinoma of the uterine cervix. (1998) (11)
Microsatellite instability associated with primary head and neck cancers and secondary esophageal cancers. (1998) (11)
LTA 252GG and GA Genotypes are Associated with Diffuse‐Type Noncardia Gastric Cancer Risk in the Japanese Population (2009) (11)
Genetic status of p53 and induction of apoptosis by radiation or isoflavones in human gastric carcinoma cell lines. (1996) (11)
Regeneration of the gastric epithelia in mice. An electron microscopic study. (1971) (11)
Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: association with Helicobacter pylori infection. (2000) (11)
Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas (1996) (11)
Microsatellite instabilities in gastric cancer patients with multiple primary cancers. (1999) (10)
Chromophobe renal cell carcinoma with osseous metaplasia: a case report. (2000) (10)
Induction and characterization of secretory differentiation in human fetal bronchial epithelial cell line (HFBE) cultured on collagen gel in growth hormone and vitamin A-supplemented medium. (1991) (10)
Alpha‐fetoprotein‐producing Immature Mediastinal Teratoma Showing Rapid and Massive Recurrent Growth in an Adult (1992) (10)
Morphometric analysis of gallbladder adenocarcinoma: Discrimination between carcinoma and dysplasia (2005) (10)
Gut endocrine cells in rat intestinal-tract carcinoma induced by 1,2-dimethylhdrazine (2004) (10)
A monoclonal antibody reacting with various human carcinomas and fetal colon and esophagus. (1985) (10)
PRIMARY MUCOSAL HYPERPLASIA OF THE GALLBLADDER (1988) (10)
nm23 protein expression in renal cell tumors: the role of the cell type. (1998) (9)
Flow Cytometric DNA Analysis of Poorly Differentialted Adenocarcinoma of the Colorectum (1991) (9)
Pathogenesis of Serrated Adenoma of the Colorectum: Implication for Malignant Progression (1997) (9)
The effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1. (1989) (9)
Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer. (1994) (9)
[Molecular diagnosis on gastrointestinal cancers]. (1994) (9)
Serotonin-containing EC cells in normal human gastric mucosa and in gastritis (1986) (9)
Effect of Epidermal Growth Factor on Rat Stomach Carcinogenesis Induced by N‐Methyl‐N′‐nitro‐N‐nitrosoguanidine (1990) (9)
Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas (2004) (9)
Abnormal expression of growth factors and their receptors in stomach cancer (1994) (8)
Fibrolipomatous hamartoma of the lung: a case report and review of the literature. (1995) (8)
Myxoid leiomyosarcoma of the stomach: a case report. (1991) (8)
Alteration and enhanced expression of the c-myc oncogene in human colorectal carcinomas. (1990) (8)
Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of the liver. (1996) (8)
[An alpha-fetoprotein producing Sertoli-Leydig cell tumor--a case report]. (1989) (8)
Morphometrical analysis of gallbladder adenoma and adenocarcinoma with reference to histogenesis and adenoma-carcinoma sequence (8)
Gastric carcinoma with lymphoid stroma: pathological and immunohistochemical analysis. (1990) (8)
Tyrosine kinase activity of epidermal growth factor receptor in human gastric carcinomas. (1992) (7)
Malignant tumors in atomic bomb survivors with special reference to the pathology of stomach and lung cancer (1986) (7)
Calcitonin in human gastric mucosa and carcinoma (2004) (7)
Growth Factors and Oncogenes in Gastrointestinal Cancers (2006) (7)
GASTRIC CARCINOMA IN A FIXED POPULATION (1970) (7)
Gut endocrine cells in rat stomach carcinoma induced by N-methyl-N′-nitro-N-nitrosoguanidine (2004) (7)
Distribution of collagen types I and III and basal lamina in human gastric carcinoma: An immunohistochemical and electron microscopic study (2004) (7)
The significance of immunochemically staining calcitonin and CEA in fine-needle aspiration biopsy materials from medullary carcinoma of the thyroid (1989) (7)
Flow cytometric analysis of the expression of 9A3 antigen, E‐cadherin and EGF receptor in TMK‐1 stomach cancer cells (2007) (7)
Argyrophil cells in early gastric carcinoma: An immunohistochemical and ultrastructural study (2004) (7)
Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma (1993) (7)
A Serine Protease‐inhibitory Benzamidine Derivative Inhibits the Growth of Human Colon Carcinoma Cells (1992) (6)
Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach (2004) (6)
No mutations of the Bub1 gene in human gastric and oral cancer cell lines. (2002) (6)
Fine structure of several types of endocrine cells in mouse gastric mucosa with special reference to the histogenesis. (1971) (6)
[Carcinoid tumor of the liver]. (2008) (6)
Endocrine Cell Tumor of the Stomach (1993) (6)
Reduced tumorigenicity and cell motility of a gastric-carcinoma cell-line by introduction of wild-type p53 gene. (1993) (6)
Induction of carcinoids in the glandular stomach of rats by N-methyl-N′-nitro-N-nitrosoguanidine (2004) (6)
AN ULTRASTRUCTURAL STUDY ON PRECANCEROUS AND CANCEROUS LESIONS OF THE GLANDULAR STOMACH IN RATS INDUCED BY N‐METHYL‐N'‐NITRO‐ N‐NITROSOGUANIDINE (1976) (6)
Pediatric tumors and secondary cancer (2000) (5)
Reduced expression of cyclin-dependent kinase inhibitor p27Kipl is an indicator of malignant behavior in oral squamous cell carcinoma (2000) (5)
[Metastasis-related genes]. (1994) (5)
Serotonin in tubular adenomas, adenocarcinomas and endocrine tumours of the stomach (1987) (5)
Endocrine cells in extrahepatic bile duct carcinoma (2004) (5)
Secretory component and immunoglobulin in human gastric carcinoma: an immunohistochemical study. (1984) (5)
BIZARRE LEIOMYOBLASTOMA OF THE CERVIX UTERI (1986) (5)
Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum. (1991) (5)
Histone Acetylation and Retinoic Acid Receptor beta DNA Methylation as Novel Targets for Gastric Cancer Therapy. (2002) (4)
Bizarre leiomyoblastoma of the cervix uteri. Immunohistochemical and ultrastructural study. (1986) (4)
EXPRESSION OF Ha‐ras ONCOGENE PRODUCT IN RAT GASTROINTESTINAL CARCINOMAS INDUCED BY CHEMICAL CARCINOGENS (1987) (4)
ENDOCRINE CELL CARCINOMA OF EXTRAHEPATIC BILE DUCT (1986) (4)
[Morphometric analysis of hepatocellular carcinoma: diagnostic usefulness of numerical nuclear density and its ratio]. (1992) (4)
[Multistep stomach carcinogenesis]. (1996) (4)
[Extramammary Paget's disease with an underlying mucinous adenocarcinoma of the buttocks]. (1988) (4)
New approaches to cancer therapy (1991) (4)
Carcinoembryonic antigen (CEA) in gallbladder bile and mucosa in cholecystolithiasis. (1986) (4)
[A case of sweat gland carcinoma arising in a mature cystic teratoma of the ovary]. (1987) (4)
Carcinogenesis and Metastasis (1993) (4)
Effects of a protein-free diet on the rat stomach. (1987) (4)
Gallstones in Gallbladder Diseases (1989) (4)
Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach (3)
Vascular transformation of lymph node sinuses in a patient with liver cirrhosis. A case report. (1988) (3)
Gastric carcinoma in a fixed population: Hiroshima and Nagasaki. (1970) (3)
Telomeres and Telomerase in Gastrointestinal Cancers (1997) (3)
[Analysis of expression of human telomerase RNA in gastric precancerous and cancerous lesions by using in situ mRNA hybridization]. (1998) (3)
Allele Frequency of D17S855 Microsatellite Locus in Japanese People (1999) (3)
Recent progress in pathogenesis and management of colorectal cancer. Eighteenth International Symposium of the Hiroshima Cancer Seminar, November 2008 (2009) (3)
[Gastric scirrhous carcinoma and growth factors]. (1988) (3)
Histopathological evaluation of microwave tissue coagulation for rat liver tumor (1996) (3)
A splice variant of the c-met proto-oncogene is the predominant population expressed in human gastric mucosa and carcinoma. (1996) (3)
Phenotypic expression of human epidermal growth factor in foetal submandibular gland and pleomorphic adenoma of salivary gland (2004) (3)
Expression of amphiregulin in human gastric cancer cell lines (3)
A monoclonal antibody capable of detecting new differentiation antigen of the stomach (1992) (3)
The effects of gastrin on the ultrastructure of rat stomach endocrine cells. (1981) (3)
Pediatric tumors and secondary cancer. The Ninth International Symposium of the Hiroshima Cancer Seminar, September 1999, Hiroshima, Japan. (2000) (2)
[Molecular mechanisms of carcinogenesis and progression of human stomach cancer]. (2001) (2)
Japan–US Cooperative Cancer Research Seminar on molecular epidemiological characteristics of lung and colon cancer development among atomic‐bomb survivors, Bethesda, USA, February 23–24, 2006 (2006) (2)
Establishment and characterization of cell line SFCC from clear cell adenocarcinoma of the uterine cervix (1989) (2)
Cloning of a human hepatocyte growth factor/scatter factor transcription variant from a gastric cancer cell line HSC-39. (2000) (2)
Expression of ERBB 2 in Human Gastric Carcinomas : Relationship between pl 85 ERBB 2 Expression and the Gene Amplification 1 (2006) (2)
Expression of Beta-1 integrin in human gastric carcinomas - correlation with histological type and tumor progression. (1994) (2)
Monoclonal antibodies against merokeratin from sheep's wool. (1991) (2)
Establishment and characterization of cell line SFCC from clear cell adenocarcinoma of the uterine cervix. (1989) (2)
Multiple Genetic Alterations and Abnormal Growth Factor Network in Human Esophageal Carcinomas (1997) (2)
[An immunohistochemical study of estrogen receptors in thyroid carcinoma]. (1990) (2)
Growth stimulatory effect of interleukin (IL)-1 alpha produced by oral squamous carcinoma cell lines. (1997) (2)
Molecular-pathological analysis of a patient with three synchronous squamous cell carcinomas in the aerodigestive tract. (1996) (2)
“Gene Diagnosis‐Introduction of New Technology”: The Tenth International Symposium of the Hiroshima Cancer Seminar, October 2000 (2001) (2)
EARLY ULTRASTRUCTURAL CHANGES OF EPITHELIAL CELLS OF THE GLANDULAR STOMACH IN RAT INDUCED BY N‐METHYL‐N'‐NITRO‐N‐NITROSOGUANIDINE (1974) (2)
[Biological malignancy in human gastric carcinoma--molecular aspects]. (1991) (2)
Expression of Epidermal Growth Factor Receptor in Human Gastric and Colonie Carcinomas 1 (2006) (2)
Modifying Effect of Chronic Atrophic Gastritis on Radiation Risk for Noncardia Gastric Cancer According to Histological Type (2020) (1)
Monoclonal antibodies against human cancer. (1985) (1)
Carcinoma Cells at Deeply Infiltrated Sites: Role in Development of Metastases in Patients with Advanced Colorectal Adenocarcinomas (1997) (1)
[New prognostic factors in human gastric carcinomas]. (1992) (1)
Gut endocrine cells in human gastric and colonic adenomas: An immunohistochemical study (1987) (1)
[New molecular prognostic markers in gastric carcinoma]. (1998) (1)
[Heterogeneity of gastrin-containing G-cells and its expression in gastric adenocarcinomas and endocrine tumors]. (1987) (1)
[Genetic characteristics of scirrhous gastric carcinomas]. (1994) (1)
Molecular Pathology of Gastroenterological Cancer: Application to Clinical Practice (2013) (1)
[Carcinogenesis through abnormalities of DNA repair genes]. (2000) (1)
Aging and cancer (1999) (1)
[Genetic alterations in gastric cancer with special reference to the histological type]. (1993) (1)
[Detection of HPV type 16 early genes E7 and E5 messenger RNA in uterine cervical neoplasia by reverse transcriptase polymerase chain reaction]. (1991) (1)
[Growth factors as biological markers of malignancy]. (1988) (1)
A STUDY OF GASTRIC MUCOSA AND ENDOSCOPIC FOLLOW-UP EXAMINATION IN PATIENTS WITH GASTRIC ADENOMA (1990) (1)
A Proposal from Molecular Biology to Clinic. Implication for Gastroinetstinal Cancer. (1994) (1)
Present State of Gene Diagnosis and Future Prospects (2002) (1)
Radiation Therapy for Cancer The Fifteenth Anniversary of Hiroshima Cancer Seminar Foundation, the Seventeenth International Symposium of Hiroshima Cancer Seminar, November 2007 (2008) (1)
Recent progress in carcinogenesis, progression and management of upper GI cancer: the 21st Hiroshima Cancer Seminar--the 5th Three Universities' Consortium International Symposium, 6 November 2011, International Conference Center Hiroshima. (2012) (1)
Cancer stem cells (2007) (1)
Histopathological observation of the heart with diffuse and abnormal proliferation of mitochondria in myocardial cells (mitochondrial cardiomyopathy): Report of an adult case (2005) (1)
[Application of antisense human telomerase RNA toward cancer therapy]. (1998) (1)
Esophageal Cancer Cell Lines Associated with Retinoid Sensitivity and Colony Formation in Is β Expression and Up-Regulation of Retinoic Acid Receptor-Updated Version (1999) (1)
Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumours A new abnormality with clinical diagnostic potential (1996) (1)
Molecular targeting therapy for cancer: The Twelfth International Symposium of the Hiroshima Cancer Seminar, November 2002 (2003) (1)
Telomerase and Cancer. The Fifth International Symposium of the Hiroshima Cancer Seminar (1996) (0)
Allele frequency of D1S191 microsatellite locus in Japanese people. (1999) (0)
[A left axillary synovial sarcoma--a case report]. (1988) (0)
[Expression of sdi1, a potent inhibitor of cdk2 kinase, cdk2 and G1 cyclins and mutation of sdi1 in human gastric carcinomas]. (1995) (0)
Galectins in Gastric and Colorectal Cancers: Implications for Tumor Progression and Metastasis (1997) (0)
[Mutations of hMSH2 gene and hMLH1 gene in human colovectal carcinomas]. (1996) (0)
GASTRIC HYPERPLASTIC POLYP IN PATIENTS WITH NORMAL ACID SECRETION (1989) (0)
Amplification of hst-1 and int-2 Genes as a Biological Marker of High Malignancy for Human Esophageal Carcinomas (1993) (0)
Expression of p16 in oral carcinomas: Relation with Rb protein expression (1997) (0)
Editorial [Hot Topic: Cancer and Stem Cells (Guest Editor: Eiichi Tahara)] (2008) (0)
The expression of stat91, ras-independent signal transducer and activator, in human gastric carcinomas. (1995) (0)
Effects of IL-10 and IL-6 Gene Polymorphisms and Atomic-bomb Radiation Exposure on Gastric Cancer Risk (2008) (0)
[Oncogene and patient prognosis]. (1991) (0)
[An undifferentiated carcinoma of the esophagus--a case of an elderly patient]. (1990) (0)
[Molecular diagnosis of gastrointestinal cancers]. (1998) (0)
[Molecular diagnosis of gastric cancer]. (1991) (0)
Aging and cancer. The Eighth International Symposium of the Hiroshima Cancer Seminar, November 1998, Hiroshima, Japan. (1999) (0)
Interleukin la Acts as an Autocrine Growth Stimulator for Human Gastric Carcinoma Cells1 (2006) (0)
[3 Cases of skin tumors]. (1969) (0)
Recent progress in carcinogenesis, progression and therapy of breast cancer: the 20th Hiroshima Cancer Seminar--the 4th Three Universities' Consortium International Symposium, October 2010: 31 October 2010, International Conference Center Hiroshima. (2011) (0)
Peptide-containing neuronal system in the human stomach wall and in gastritis mucosa: An immunohistochemical study (1988) (0)
Gene therapy: application to disease. The Seventh International Symposium of the Hiroshima Cancer Seminar, November 1997, Hiroshima, Japan. (1998) (0)
Identification of immunologically high-risk individuals of stomach cancer and application to cancer prevention (2006) (0)
Concluding comment: New approaches to cancer therapy and prevention (1996) (0)
ENDOSCOPIC STUDY OF GASTRIC ADENOMAS WITH COEXISTENT ADENOCARCINOMA AT A DIFFERENT SITE AND FOCAL CANCER (ADENOCARCINOMA IN ADENOMA) (1990) (0)
Regulation ofCarcinoembryonic Antigen Expression inHumanColonCarcinoma Cells by theOrganMicroenvironment (1996) (0)
Relationship of intestinal- and diffuse-type gastric cancer risks to IL-10 Haplotypes and effects of radiation exposure on the relationship (2008) (0)
Proton pump inhibitors (PPI) reduce cell cycle abnormalities in Barrett's esophagus (BE) (1998) (0)
DNA REPLICATION ERRORS IN FOUR FAMILIAL GASTRIC CANCERS (1998) (0)
Gastric cancer: Genetic model of gastric cancer (1999) (0)
[Molecular pathological diagnosis of cancer]. (1990) (0)
Research and Emerging Technology Paper Head and Neck Oncology (2002) (0)
Gastric Cancer (1993) (0)
New approaches to identification of biomarkers for early cancer detection: The Thirteenth International Symposium of the Hiroshima Cancer Seminar, October 2003 (2004) (0)
Gastric and Colonic Carcinomas Expression of Epidermal Growth Factor Receptor in Human Updated Version (2006) (0)
Cancer Incidence / Colorectal cancer / Atomic bomb survivors / Life Span Study / Dose response (2006) (0)
[Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene]. (2001) (0)
[Stomach cancer and growth factors]. (1989) (0)
Increased expression and phosphorylation of sh-ptp2 (syp) in human gastric carcinomas. (1995) (0)
Current progress of cancer chemotherapy The Fifteenth International Symposium of the Hiroshima Cancer Seminar, October 2005 (2006) (0)
[Genetic analysis of malignant solid tumors]. (1999) (0)
[Stomach cancer]. (1997) (0)
MYOGENIC TUMORS OF THE STOMACH : A CLINICO-PATHOLOGICAL STUDY (1990) (0)
Abstracts of Selected Papers Presented at the 28th Annual Meeting of the Japanese Society of Gastroenterology Kanazawa, Japan, October 1–3,1986 (2007) (0)
[An overview of research on p53 tumor suppressor gene]. (1997) (0)
Telomerase activity in bladder carcinomas and its implications to non-invasive detection by exfoliated cancer cells in urine (1996) (0)
MALIGNANT LYMPHOMA OF THE STOMACH SHOWING MARKED CHANGES OF THE ENDOSCOPIC FINDINGS IN A SHORT PERIOD, ROPORT OF A CASE (1987) (0)
Immunohistochemical analysis of colorectal cancer among atomic bomb survivors in Hiroshima. (1987) (0)
[Growth factors in human gastrointestinal carcinomas]. (1991) (0)
[Abnormal transcription of cell adhesion molecule CD44 in human gastric carcinomas]. (1995) (0)
Gene therapy: application to disease (1998) (0)
The Third International Symposium of the Hiroshima Cancer Seminar: Tumor-suppressor genes (1994) (0)
Scirrhous endocrine cell carcinoma of the stomach with synchronous production of six polypeptide hormones and glycoproteins. A case report. (1985) (0)
9 Detection of HPV types 16 and 18 early gene E7 messenger RNA in uterine cervical cancers by polymerase chain reaction. (1991) (0)
Growth Inhibitory Effect of Inter 1 eron-Is Associated with the Induction of Cyclin-dependent Kinase Inhibitor p 2 lkuPl in a Human Gastric Carcinoma Cell Line 1 (2005) (0)
Mycosis fungoides of erythematous stage. (1992) (0)
[A case of lobular carcinoma of the breast containing endocrine granules]. (1985) (0)
Chromatin and Cancer: The Eleventh International Symposium of the Hiroshima Cancer Seminar, November 2001 (2002) (0)
Skin tumor of the face. (1989) (0)
[Monoclonal antibody 9A3 raised against a human poorly differentiated gastric adenocarcinoma cell line]. (1986) (0)
A Role of Pathologists in Clinical Practice of the 21st Century (1998) (0)
Concluding comment: New approaches to cancer therapy and prevention (0)
Peptide-containing nerve in the rat stomach: an immunohistochemical study. (1988) (0)
Molecular diagnosis of gastrointestinal cancers: The application to clinical practice (1996) (0)
Cancer and epigenetics – basic research and clinical implications: Joint Meeting of the Fourteenth International Symposium of the Hiroshima Cancer Seminar and the Eighth Meeting of the Tottori Bioscience Promotion Foundation, October 2004 (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eiichi Tahara?

Eiichi Tahara is affiliated with the following schools:

Hiroshima University

Eiichi Tahara's Academic­Influence.com Rankings

Eiichi Tahara's Degrees

Why Is Eiichi Tahara Influential?

Eiichi Tahara's Published Works

Published Works

What Schools Are Affiliated With Eiichi Tahara?

Eiichi Tahara's AcademicInfluence.com Rankings